Phase I-II of the update of the EORTC Quality of Life Gastricmodule QLQ-STO22 - EORTC-QOQ-STO_22

niversity of Southampton0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Histologically proven as gastric adenocarcinoma with disease stages I-IV (UICC TNM 8th)
•2. Patients with a gastric or junction cancer whose epicenter is located within 2 cm of the
•oesophagogastric junction
•3. Patients receiving treatment(either currently or within the last 12 months) including a systemic
•treatment (chemotherapy, target agents, and immunotherapy), surgical resection, and radiotherapy or receiving supportive or palliative care
•4. Patients who are willing and able to give fully informed consent to participate
•5. Patients who are literate in English or Hindi

•1. Patients under 18 years of age
•2. Patients with a concurrent malignancy
•3. Cancer survivors defined as people who have completed treatment with curative intent more than 12 months ago and are now cancer-free.
•4. Patients enrolled in other quality of life studies which will affect the results of the current study

发起方

niversity of Southampton